64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation
Clinical trial NCT05728372 · WITHDRAWN
Trial details
- NCT number
- NCT05728372
- Sponsor
- City of Hope Medical Center
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-25
- Primary completion
- 2026-11-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.